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Abstract
Background: The acceptability, feasibility and effectiveness of web-based interventions among criminal justice
involved populations are understudied. This study is a secondary analysis of baseline characteristics associated with
criminal justice system (CJS) status as treatment outcome moderators among participants enrolling in a large
randomized trial of a web-based psychosocial intervention (Therapeutic Education System [TES]) as part of
outpatient addiction treatment.
Methods: We compared demographic and clinical characteristics, TES participation rates, and the trial’s two co-
primary outcomes, end of treatment abstinence and treatment retention, by self-reported CJS status at baseline: 1)
CJS-mandated to community treatment (CJS-mandated), 2) CJS-recommended to treatment (CJS-recommended), 3)
no CJS treatment mandate (CJS-none).
Results: CJS-mandated (n = 107) and CJS-recommended (n = 69) participants differed from CJS-none (n = 331) at
baseline: CJS-mandated were significantly more likely to be male, uninsured, report cannabis as the primary drug
problem, report fewer days of drug use at baseline, screen negative for depression, and score lower for
psychological distress and higher on physical health status; CJS-recommended were younger, more likely single,
less likely to report no regular Internet use, and to report cannabis as the primary drug problem. Both CJS-involved
(CJS -recommended and -mandated) groups were more likely to have been recently incarcerated. Among
participants randomized to the TES arm, module completion was similar across the CJS subgroups. A three-way
interaction of treatment, baseline abstinence and CJS status showed no associations with the study’s primary
abstinence outcome.
Conclusions: Overall, CJS-involved participants in this study tended to be young, male, and in treatment for a
primary cannabis problem. The feasibility and effectiveness of the web-based psychosocial intervention, TES, did not
vary by CJS-mandated or CJS-recommended participants compared to CJS-none. Web-based counseling
interventions may be effective interventions as US public safety policies begin to emphasize supervised community
drug treatment over incarceration.
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Background
The US criminal justice system (CJS) population is com-
posed primarily of adults with substance use disorders,
chiefly through arrests and convictions for activities to
sustain illicit drug use or for offenses committed under
the influence of drugs and alcohol (Carson and Golinelli,
2013; Feucht and Gfroerer, 2011; Field, 1989). Incarcer-
ated populations are more than 13 times more likely to
be dependent on drugs than the general population
(Fazel et al., 2006), and will likely struggle with sub-
stance use disorders upon community re-entry. Commu-
nity drug treatment interventions, including pre-trial
diversion, community supervision, and problem-solving
court programs (e.g. drug courts, mental health courts),
are increasingly being implemented as cost-saving and
evidence-based public health alternatives to incarcer-
ation (Feucht and Gfroerer, 2011). U.S. sentencing trends
and national guidelines have been prioritizing drug treat-
ment over incarceration for non-violent drug related of-
fenses (ONDCP, 2013).
Once in community treatment, CJS-involved patients
may have unique characteristics and prognoses. CJS vs.
non-CJS treatment populations are disproportionately
poor, unemployed, have lower literacy rates (Greenberg
et al., 2007; Hudson, 1987), and have worse mortality
and general health outcomes than non-CJS age-matched
populations (Binswanger et al., 2007; Greenberg et al.,
2007). The outcome data for mandated versus voluntary
substance abuse treatment in the criminal justice system
is mixed. Mandated, compared to voluntary treatment
may compel unmotivated or even hostile participants
into unwanted treatment, making positive treatment
outcomes less likely even if retention rates are better
(Perron and Bright, 2008). Other studies have shown
that mandated treatment outcomes are generally identi-
cal and often better compared to voluntary treatment in
CJS-involved populations (Farabee et al., 1998; NIDA,
2014; Taxman, 1998). Further studies of CJS-involved in-
dividuals in community drug treatment programs have
revealed mixed outcomes compared to non-CJS treat-
ment populations (Farabee et al., 1998; Lee et al., 2012).
A recent study of male probationers demonstrated
greater unmet needs for substance abuse treatment com-
pared to non-CJS substance abusers (Feucht and
Gfroerer, 2011).
Novel community addiction treatment interventions,
including health technology-based interventions, may
have variable effects depending on patient sub-
populations and CJS status. An important area of health
technology innovation is web- or Internet-based drug
and alcohol counseling. Compared to traditional face-to-
face counseling, web-based or other mobile health
(‘mHealth’) psychosocial interventions may be more
scalable as a result of cost efficiencies and accessibility
(Carroll and Rounsaville, 2010; Marsch and Dallery,
2012). Few studies have assessed computer and Internet
literacy and the feasibility of these interventions in CJS
populations (Alemagno et al., 2009; Chaple et al., 2013;
Ford and Vitelli, 1992; Walters et al., 2014). Even fewer
have been conducted amongst community-dwelling CJS-
involved treatment populations with real-time Internet
access, as opposed to non-Internet, computer-based
modules (Alemagno et al., 2009; Walters et al., 2014). To
our knowledge, only one web-based substance use inter-
vention specifically for CJS-involved persons is in devel-
opment (Walters et al., 2014).
The objective of this secondary data analysis was to
compare baseline demographics and clinical characteris-
tics and treatment outcomes of CJS-involved partici-
pants to participants with no apparent CJS involvement
entering a national multisite web-based psychosocial ad-
diction treatment study (WEB-TX) (Bickel et al., 2008;
Campbell et al., 2012). This study was funded and con-
ducted by NIDA's Clinical Trials Network (NIDA CTN).
WEB-TX had broad inclusion and few exclusion criteria
and was intended to draw a diverse sample of patients
seeking treatment for drug or alcohol problems in
community-based treatment programs in the United
States. Based on previously described disadvantages
among CJS-involved populations, including lower
educational achievement, employment, and computer
literacy, we hypothesized CJS-involved participants
would have more severe addiction disorders, more psy-
chiatric co-morbidities, and report less Internet use at
baseline compared to participants with no reported
CJS involvement. Similarly, we hypothesized CJS-
involved participants would have poorer treatment
outcomes overall, including less web-based intervention




Full details about the study have been described previ-
ously (Campbell et al., 2012). Briefly, the impact of a
web-based version (Bickel et al., 2008) of the Commu-
nity Reinforcement Approach (Hunt and Azrin, 1973),
including prize-based contingency management (Budney
et al., 1991), was assessed among 507 participants en-
rolled in 10 outpatient substance abuse treatment pro-
grams located across the United States. Potential
participants were informed about the opportunity to
participate in the trial at the time they entered one of
the collaborating treatment programs. Eligible partici-
pants were in the first 30 days of the current treatment
episode, reported using an illicit substance within the
30 days prior to screening, and were not receiving opioid
replacement medications such as methadone or
Lee et al. Health and Justice  (2017) 5:3 Page 2 of 9
buprenorphine. Of the 1,781 participants screened, 848
were ineligible (47.6%), 426 (23.9%) were eligible but did
not enroll in the study, and 507 (28.5%) were eventually
randomized. The primary reasons for ineligibility were:
no illicit substance use in the 30 days prior to screening
(83.5%); not planning a treatment episode of at least
90 days (11.8%); in the current treatment episode greater
than 30 days (8.5%); and currently prescribed an opioid
replacement therapy (7.9%).
Study design and intervention
Enrolled participants were randomly assigned to
12 weeks of: (1) treatment-as-usual (TAU); or (2) modi-
fied TAU + Therapeutic Education System (TES),
whereby TES substituted for approximately 2 h of usual
care (i.e., clinician-delivered groups). All participants
were asked to provide self-reported substance use and
urine drug and breath alcohol screens twice per week
during the treatment phase. TES (Bickel et al., 2008;
Campbell et al., 2014) includes 62 web-delivered multi-
media modules or topics which focus on cognitive
behavioral relapse prevention skills, psychosocial func-
tioning, and HIV and other sexually transmitted infec-
tion prevention and treatment information. Participants
were asked to complete at least 4 modules per week; that
is, 48 of the 62 modules over the 12 week treatment
phase. The contingency management component of TES
is a prize-based incentive system (Petry et al., 2005; Stit-
zer et al., 2010) whereby participants can earn intermit-
tent prizes for submitting negative urine/breath alcohol
screens and completing TES modules (up to 4 per
week).
Measures
Demographic variables included sex, age, race/ethncity,
education, marital status, employment status, criminal
justice drug treatment status, and lifetime incarceration
and criminal behavior history. Criminal justice status
was categorized into 3 subgroups per a single self-
reported item about whether participants were man-
dated or recommended for treatment by CJS authorities:
CJS-mandated, CJS-recommended, or CJS-none. Fre-
quency of Internet use was a self-reported categorical
measure, inquiring how often participants accessed the
Internet in the past 30 days.
Screening for major depressive disorder, generalized
anxiety disorder and panic disorder was completed using
the Patient Health Questionnaire (PHQ) (Spitzer et al.,
1999; Spitzer et al., 2006). The Brief Symptom
Inventory-18 (Derogatis, 2000) (total global score) mea-
sured overall psychological distress level. Primary sub-
stance of abuse and age of onset of substance use
dependence were both collected using the DSM-IV
symptom questionnaire (Hudziak et al., 1993). The
Coping Strategies Scale (Litt et al., 2003; Litt et al., 2012)
(total number of endorsed strategies (0–23); endorsed
strategies are those used occasionally or frequently)
assessed change processes used in altering substance use
behavior. The Euro Quality of Life Scale-EQ5D (Euro-
Qol Group, 1990) assessed participants’ perception of
their physical health using a visual analogue scale (range
0–100; where 100 is the best health). Medical service
utilization was measured for the 30 days prior to initial
enrollment into the study and included number of doc-
tor visits, emergency department visits, and hospital
admissions.
The MicroCog computerized Assessment of Cogni-
tive Functioning has been normalized and standardized
for adults (Powell et al., 1993). Based on our previous
work (Aharonovich et al., 2008), a custom version of
the MicroCog (20–25 min in length) was used to mea-
sure working memory (Numbers Forward and Re-
versed), immediate/delayed memory (Wordlist 1 and
2), logical association of familiar concepts (Analogies),
and spatial recognition/logic (Object Match A and B;
Clocks). Subtest raw scores were transformed to scaled
scores (μ = 10.0, σ = 3.0) and descriptively defined
(Powell et al., 1993) as: μ ≤ 4 (below average), 8 > μ > 4
(low average), 13 > μ ≥ 8 (average), and μ ≥ 13 (above
average).
Acceptability of the TES intervention was measured
on a 0–10 point scale (higher scores corresponding to
greater acceptability) using 5 indicators: how interest-
ing, how useful, quantity of new information, how easy
to understand, and how satisfied. Participants com-
pleted the measure at the end of the 12-week treatment
phase.
Abstinence from drugs and alcohol was evaluated
twice weekly during the 12-week treatment phase. Ab-
stinence was defined as a negative urine toxicology test
for 10 drugs of abuse and self-reports indicating no drug
or alcohol use measured using the Timeline Follow Back
method (Sobell and Sobell, 1992). Abstinence data was
considered missing if the urine screen was missing or if
the urine screen was negative and the self-report was
missing. The outcome was a binary measure of abstin-
ence (yes or no) throughout the last 4 weeks of treat-
ment (i.e., weeks 9–12).
Statistical analysis
Either the χ2 test, F-test, or the Kruskal-Wallis test
(non-parametric equivalent of the one-way independ-
ent ANOVA) was used to compare CJS-mandated
and CJS-recommended with CJS-none across baseline
variables of interest. A p-value of < .05 was considered
significant. Neurocognitive testing scores were ad-
justed for age, education, and baseline abstinence
status.
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The study’s primary outcomes, abstinence throughout
the final four weeks of treatment and retention at week
12 (dichotomous, yes or no), were analyzed using gener-
alized linear mixed effect models (with logit link con-
ducted with Proc GLIMMIX in SAS). The generalized
linear mixed model is used to handle correlated data
from repeated measurements on categorical outcomes
and provides robust inference with respect to misspecifi-
cation of within-subject correlation (Breslow and Clay-
ton, 1993). Models included treatment arm (TES vs.
TAU), CJS subgroup, and abstinence at baseline and site
and subject were treated as random effects. Interactions
between treatment, CJS subgroup, and abstinence at
baseline were tested and included in the final model if
significant at p < .05. Time was included in the model
testing abstinence (n = 469); 38 cases were removed that
were missing all four weeks of data. The correlation be-
tween the repeated measurements within-subject was
modeled using the first-order auto regressive structure.
Missing data was assumed missing at random and this
differential attrition did not impact analysis of the pri-
mary outcome. All analyses were conducted using SAS
version 9.3.
Results
Demographic, internet use, substance use, general health
baseline characteristics
Table 1 presents baseline demographic features of the
randomized sample. Overall, the two CJS-involved
groups were more likely to be male, younger, and using
cannabis as a primary drug versus opioids. CJS-
mandated compared to CJS-none were significantly
more likely to be male, uninsured, report more cannabis,
alcohol, and stimulants as the primary drug problem, re-
port fewer days of drug use at baseline, screen negative
for depression, and score lower for psychological distress
and higher on physical health status; CJS-recommended
compared to CJS-none were younger, more likely single,
to report cannabis as the primary drug problem, and
have a lower proportion reporting daily Internet use
(35%).
Recent incarceration and self-reported criminal activity
The mean days of self-reported criminal activity ob-
tained at baseline were similar across CJS subgroups; on
average 4–6 days of the last 90 days were characterized
by criminal behavior, the most common of which were
directly drug-related (sale, possession) or driving while
intoxicated [Table 2]. As expected based on self-reported
CJS treatment mandates, CJS-mandated and CJS-
recommended reported significantly higher rates of re-
cent incarceration (35% and 39% vs. 13%, p < 0.001).
Neurocognitive data
Table 3 presents baseline neurocognitive data for the
scaled scores on the MicroCog (Drozdick et al., 2004)
subtests. Scores were age and education-adjusted. The
CJS -mandated and –recommended groups performed
significantly better on subtests of working memory
(Numbers Reversed) compared to CJS-none. Other sub-
tests, such as attention and concentration (Numbers
Forward), reasoning, cognitive flexibility and spatial pro-
cessing did not differ significantly.
TES module completion and acceptability
Among participants randomized to the TES arm, module
completion was similar across the CJS subgroups. Total
modules completed were M= 37.2 (SD = 16.7) for the
non-CJS subgroup, M = 36.2 (SD = 17.1) for the CJS-
recommended subgroup and M= 36.2 (SD = 17.3) for the
CJS-mandated subgroup (out of a recommended 48 mod-
ules or 4 modules per week for 12 weeks). Acceptability of
TES (on a scale of 0–10, with 10 corresponding to higher
acceptability) was high among all CJS subgroups: M = 8.25
(SD = 1.56), M = 8.40 (SD = 1.76), and M= 8.33 (SD =
1.51) among none-CJS, CJS-recommended, and CJS-
mandated subgroups, respectively.
Abstinence during the last four treatment weeks and
treatment retention
The primary outcome of the randomized trial was drug
and alcohol abstinence in the final four weeks of treat-
ment. Final four-week abstinence was tested as a func-
tion of treatment arm, baseline abstinence (i.e., baseline
urine drug and breath alcohol negative), CJS status, and
time (Table 4). The three-way interaction of treatment,
baseline abstinence and CJS status was not significant
(p = 0.41). Per the trial’s main results, there was a two-
way interaction between treatment arm and baseline ab-
stinence (p = .080) whereby among participants not ab-
stinent at baseline, the TES treatment effect, compared
to treatment-as-usual, was significant (p = .003). There
were no significant effects of TES, regardless of baseline
abstinence status, within the three CJS subgroups.
Retention in the outpatient treatment program at week
12 was tested as a function of treatment arm, baseline
abstinence, and CJS status. The three-way and two-way
interactions were not significant. Treatment retention by
CJS subgroup neared significance but did not meet the
p < .05 threshold (p = .06): CJS-mandated (50.5%), CJS-
recommended (52.2%), and CJS-none (39.9%). After
controlling for treatment arm and baseline abstinence in
the final model, differences in treatment retention by
CJS subgroup (p = .169) were not significant. Also in the
final model, baseline abstinence (p = .013) and treatment
(p = .069, a trend level of significance) were associated
with greater retention
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Discussion
This analysis of self-reported baseline criminal justice
status upon entry into a randomized controlled trial of
web-based addiction treatment indicated several notable
findings: compared to participants with no reported CJS
involvement, those mandated or recommended to treat-
ment by CJS authorities were younger, more likely to be
male, and more cannabis-involved. Regardless of CJS-
Table 1 Baseline demographic and clinical characteristics of the randomized sample (N = 507) as a function of criminal justice
system (CJS) involvement








Mean (SD) or % F or χ2. P-value
Age 36.08 (10.80) a 30.93 (10.90) b 33.78 (10.54) ab F (2, 504) = 7.28, p < .001
Female 41.82a 31.88ab 29.91b x2 (2) = 6.12, p = .047
Race/Ethnicity x2 (6) = 6.56, p = .36
White (ref.) 55.89 52.17 42.99
Black 21.45 21.74 24.30
Hispanic/Latino 10.27 10.14 13.08
Other/Mixed 12.39 15.94 19.63
Education x2 (4) = 4.05, p = .40
< High School 21.45 30.43 24.30
High School 61.33 56.52 63.55
> High School 17.22 13.04 12.15
Employed 41.99 40.58 39.25 x2 (2) = 0.26, p = .88
Single/Never Married 56.80a 73.91b 64.49ab x2 (2) = 7.81, p = .02
Internet Use (90d) x2 (6) = 14.60, p = .02
None (no) 27.49 21.74 25.23
Less than once/week 7.25 10.14 5.61
At least once/week 15.41 33.33 20.56
At least once/day (ref) 49.85 34.78 48.60
Insurance (90d) 78.25a 73.91ab 65.09b x2 (2) = 7.43, p = .02
Baseline drug abstinence 53.47 53.62 57.01 x2 (2) = 0.42, p = .81
Days of any Substance Use (90d) 47.47 (27.06) a 44.29 (27.13) a 36.02 (25.54) b x2 (2) = 14.70+, p < .001
Age of Onset (Dependence) 22.82 (9.00) 20.38 (7.78) 21.47 (6.73) F (2, 460) = 2.29, p = .11
Years of Substance Use (Dependence) 13.22 (10.66) 10.67 (8.90) 12.83 (10.06) x2 (2) = 2.27+, p = .32
Primary Substance x2 (10) = 24.12, p = .007
Alcohol 20.54 13.04 25.23
Cocaine 22.05 24.64 11.21
Other Stimulants 12.08 11.59 19.63
Opioids (ref.) 24.47 20.29 12.15
Cannabis 18.73 28.99 29.91
Other 2.11 1.45 1.87
Current Depressive Disorder 24.17a 17.39ab 13.08b x2 (2) = 6.61, p = .04
Current Generalized Anxiety Disorder 29.61 23.19 24.30 x2 (2) = 1.92, p = .38
Current Panic Disorder 17.52 23.19.20 16.82 x2 (2) = 1.39, p = .50
Psychological Distress (Brief Symptom
Inventory)
14.38 (12.62) a 12.49 (12.31) ab 11.51 (12.37) b x2 (2) = 8.87+, p = .02
Physical Health (0–100) 72.24 (19.67) a 70.03 (21.68) a 76.85 (17.78) b x2 (2) = 6.17+, p = .046
Social Adjustment Total Score 2.21 (0.48) 2.17 (0.54) 2.09 (0.50) F (2, 504) = 1.71, p = .18
a-b Different superscripts indicate statistical significance at p < .05 for pairwise comparisons between two criminal justice groups
+ Non-parametric Kruskal-Wallis tests were used
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status, all participants experienced the trial or the TES
web-based psychosocial intervention in a similar fashion;
there were no differences observed in the rate of TES
participation, retention in treatment, or end-of-study
drug and alcohol abstinence. These findings demonstrate
a high level of feasibility and acceptability of web-based
interventions among community-based addiction treat-
ment attendees, including those that are involved to
varying degrees with the CJS system.
While CJS-involved populations may have more un-
met treatment needs (Fazel et al., 2006; Feucht and
Gfroerer, 2011), our findings generally were contrary to
our hypotheses that criminal justice involved individuals
would show greater levels of impairment and less suc-
cess in web-based treatment; there were no differences
in terms of TES initiation, completion, or the trial’s main
outcomes of retention and abstinence across the three CJS
subgroups. Our hypotheses were based on prior studies
characterizing CJS populations as disproportionately poor
and unemployed, with low literacy rates and worse mor-
tality and general health outcomes (Binswanger et al.,
2007; Greenberg et al., 2007; Hudson, 1987). Additionally,
we considered prior studies suggesting that mandated
treatment outcomes were often worse compared to other
populations (Perron and Bright, 2008; Simpson et al.,
1997; Taxman, 1998).
The sample as a whole showed impairment (e.g. rela-
tively low educational attainment, low employment, and
relatively higher rates of anxiety and depression), neuro-
cognitive tests below population norms in general, and
increasingly lower neurocognitive scores as tests in-
creased in difficulty (e.g. from Numbers Forward to
Numbers Reversed). Due to an assumption of potentially
lower socioeconomic status and educational achieve-
ment, we expected lower rates of Internet use and lower
neurocognitive ratings among CJS-involved participants,
neither of which were found. If anything, the data sug-
gest that within this relatively impaired overall sample of


















Days of criminal activity 4.94 (16.08) 5.14 (15.83) 4.41 (16.69)
% Committed, Charged or Convicted
Drug dealing or drug charges 15.41 31.88 18.69
Shoplifting/theft/auto 14.0 15.94 9.35
Robbery/burglary 2.11 10.14 2.80
Aggravated assault 4.83 5.80 2.80
Sexual assault 0.00 0.00 0.00
DUI 19.94 27.54 20.56
Other 6.95 24.64 19.63
a-b. Difference in % participants detained/incarcerated, p < 0.001
Table 3 Baseline Age/Education-Adjusted Neurocognitive Data (N = 507)
MicroCog Subtest Scaled
Scores
Illegal Behavior/Criminal Justice Involvement Significance Between
GroupsaCJS-none (n = 331) CJS-Recommended (n = 69) CJ Mandated (n = 176)
Mean (SD) F-test, p value
Numbers Forward Total Score 8.41 (2.70) 8.94 (2.56) 8.94 (2.85) F (2, 503) = 2.49, p = .08
Numbers Reversed Total Score 7.90 (2.51) 8.88 (3.08) 8.41 (2.87) F (2, 503) = 4.60, p = .01b
Wordlist 1 Total Score 7.40 (4.59) 7.32 (4.58) 7.91 (4.18) F (2, 502) = 0.54, p = .59
Wordlist 2 Total Score 9.62 (3.17) 9.59 (3.33) 9.73 (3.29) F (2, 502) = 0.04, p = .96
Analogies Total Score 6.71 (2.90) 6.48 (2.57) 6.79 (2.92) F (2, 503) = 0.28, p = .75
Object Match A Total Score 8.30 (3.86) 8.42 (4.31) 8.08 (3.82) F (2, 499) = 0.19, p = .83
Object Match B Total Score 8.50 (3.16) 8.62 (3.37) 8.88 (2.95) F (2, 498) = 0.60, p = .55
Clocks Total Score 11.00 (1.85) 10.77 (2.04) 11.16 (1.71) F (2, 503) = 0.94, p = .39
a adjusted for baseline abstinence
b. Numbers reversed total scores is lower in CJS-none than CJS-recommended group. (t = 2.79, p < .01)
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treatment seekers, those with criminal justice involve-
ment may have less impairment, and be more ready to
benefit from a computer-delivered intervention. The
younger age of the criminal justice involved patients
might explain some of these results, such as a higher
overall proportion reporting some recent Internet use.
Younger addiction treatment entrants are generally more
likely to use the Internet (Cohall et al., 2011), which may
have applied to CJS-involved participants in this study.
Further, because the CJS-involved participants in this
study were able to seek outpatient drug treatment, as
opposed to serving jail time, it may be that their criminal
histories were shorter and less involved (e.g., infractions
related to driving under the influence or possession of
cannabis). This would also account for the small number
of differences found between the CJS subgroups.
Other studies have found computer-delivered inter-
ventions to be successful with CJS involved patients. In-
mates completing an attitudinal survey were highly
receptive towards receiving computerized adjunct psy-
chotherapy and were “equally divided” between receiving
computerized versus clinician-delivered therapy sessions
(Ford and Vitelli, 1992). Participants agreed that the
computer sessions were “a good use of time”, “enjoy-
able”, and “interesting” (Ford and Vitelli, 1992). A ran-
domized trial (Alemagno et al., 2009) examined the
effectiveness of a brief computerized motivational inter-
vention compared to usual education activities, assessing
whether it could decrease HIV risk-behaviors and in-
crease HIV testing among a community-supervised
population (i.e. probationers). At 2-months post inter-
vention, the number of those who obtained HIV testing
were significantly higher in the experimental vs. control
group. Furthermore, those randomized to the computer-
ized intervention appeared to have increased positive at-
titudes towards changing their risk and awareness of
HIV (Alemagno et al., 2009). In a recent clinical trial
using TES in 10 state prisons, results showed high rates
of TES module completion, improvements in copings
skills, and a “more favorable view” of TES than of stand-
ard care, which consisted of 2 h, weekly group sessions
with a certified Addictions Counselor (Chaple et al.,
2013). Although this research is promising, Internet-
delivered treatment has been largely unexplored in a
community setting, under everyday pressures, although
studies are underway (Walters et al., 2014). The current
study is a step to begin filling this knowledge gap by ex-
ploring computer literacy and web-based treatment
among community-based, CJS-involved individuals with
substance use disorders.
This analysis has several strengths, including compre-
hensive assessment of baseline patient characteristics,
and a large sample drawn from a wide variety of out-
patient clinical treatment programs across the United
States. There are also clear limitations. First, since par-
ticipants were selected from outpatient programs, these
findings may not be generalizable to other populations,
such as inpatient or incarcerated populations. Second,
since eligibility criteria required at least some recent
(past 30 days) illicit substance use, participants with al-
cohol use disorders only and no other drug use were not
included. Third, our assessment of medical and psychi-
atric morbidity was limited, only relying on self-report.
A more comprehensive medical and psychiatric assess-
ment with collateral history from participants’ families
or their primary care physicians might have yielded dif-
ferent findings. Fourth, our categorization of CJS status
was gathered from a single baseline questionnaire item,
was not confirmed with administrative CJS data, and
may contribute to a loss of information about individual
differences (Altman and Royston, 2006). Finally, we do
not know if the neurocognitive data reflect premorbid
capacity or substance-induced cognitive changes, which
could have been further teased out with collateral
history.
Conclusions
In summary, this secondary analysis reveals that CJS
participants entering outpatient addiction treatment are
more likely young, male, and cannabis-involved. Baseline
Internet use, web-based treatment uptake, and end-of-
study abstinence and retention outcomes did not vary
significantly by CJS status, implying CJS-involved partic-
ipants are as likely to use a web-based psychosocial
intervention and achieve similar outcomes as general pa-
tient populations. We detected no differences in the TES
intervention’s effects by the three CJS classes, nor did
these sub-groups confound an earlier overall finding of
Table 4 Generalized Linear Model for Abstinence in the Final Four Weeks of Treatment by Treatment Arm, Baseline Abstinence, CJS
Status, and Time
F-test p-value
Time F (1, 2450) = 0.13 .717
Baseline Abstinence F (1, 2450) = 58.28 <.001
Treatment Arm (TES vs. TAU) F (1, 2450) = 6.98 .008
CJS Status (None, Recommended, Mandated) F (2, 2450) = 1.75 .174
Treatment x Baseline Abstinence F (1, 2450) = 3.07 .080
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baseline abstinence predicting treatment retention. CJS-
involved participants appeared to experience the usual
expected benefits in this large multisite randomized trial.
These results should encourage treatment providers,
policy makers, and CJS authorities to further consider
online psychosocial interventions as viable and appropri-
ate therapeutic approaches in CJS addiction treatment
populations.
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